Retractable Technologies (NYSE:RVP) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Retractable Technologies (NYSE:RVP) in a research note released on Saturday. The brokerage issued a hold rating on the stock.

Retractable Technologies Stock Performance

RVP stock opened at $0.94 on Friday. Retractable Technologies has a twelve month low of $0.87 and a twelve month high of $1.34. The firm has a market cap of $28.00 million, a price-to-earnings ratio of -3.60 and a beta of 2.08. The business’s fifty day simple moving average is $1.08 and its two-hundred day simple moving average is $1.11. The company has a quick ratio of 6.54, a current ratio of 9.51 and a debt-to-equity ratio of 0.01.

Retractable Technologies (NYSE:RVP) last announced its quarterly earnings data on Wednesday, August 14th. The company reported ($0.48) earnings per share for the quarter. The company had revenue of $6.03 million for the quarter. Retractable Technologies had a negative net margin of 46.72% and a negative return on equity of 18.67%.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.